HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of treatment modalities for psoriasis.

Abstract
Although there is no cure for psoriasis, a variety of treatments are available to reduce the severity of symptoms and lessen their impact on the patient's quality of life. For patients with less than 20% body surface involvement, topical therapy is the most appropriate choice for initial treatment. Commonly used topical therapies include corticosteroids; calcipotriene, a vitamin D analogue; tazarotene, the first retinoid to be approved for the treatment of psoriasis; and anthralin. Each of these treatments is effective in mild to moderate psoriasis, but each is also associated with varying degrees of safety and tolerability concerns. For patients with more severe, recalcitrant, or extensive psoriasis, phototherapy and systemic therapies are available. These therapies are more effective than topical therapy, but are also associated with significant cutaneous and systemic adverse effects. Phototherapy, alone or in combination with coal tar or psoralen, is very effective in the treatment of moderate to severe psoriasis, but can lead to erythema and pruritus acutely, and long-term problems such as wrinkling, solar elastosis, and an increased risk of skin cancer. Systemic therapies such as acitretin, methotrexate, cyclosporine, hydroxyurea, and thioguanine are also very effective in the treatment of moderate to severe psoriasis, but are all associated with significant systemic toxicity, which requires that patients be monitored carefully. Ultimately, treatment selection for each patient must take into account both the patient's disease severity and expectations for improvement, as well as the risk-benefit ratio associated with each potential therapy.
AuthorsP Tristani-Firouzi, G G Krueger
JournalCutis (Cutis) Vol. 61 Issue 2 Suppl Pg. 11-21 (Feb 1998) ISSN: 0011-4162 [Print] United States
PMID9787987 (Publication Type: Journal Article, Review)
Chemical References
  • Dermatologic Agents
Topics
  • Administration, Topical
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Dermatologic Agents (administration & dosage)
  • Humans
  • PUVA Therapy (methods)
  • Phototherapy (methods)
  • Psoriasis (drug therapy, therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: